It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDSX’s FA Score shows that 0 FA rating(s) are green whileWRBY’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDSX’s TA Score shows that 4 TA indicator(s) are bullish while WRBY’s TA Score has 3 bullish TA indicator(s).
BDSX (@Medical Specialties) experienced а +10.27% price change this week, while WRBY (@Pharmaceuticals: Other) price change was -1.14% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +4.25%. For the same industry, the average monthly price growth was +1.87%, and the average quarterly price growth was -1.45%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.86%. For the same industry, the average monthly price growth was -3.35%, and the average quarterly price growth was +2.88%.
BDSX is expected to report earnings on Oct 31, 2025.
WRBY is expected to report earnings on Nov 06, 2025.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Pharmaceuticals: Other (+1.86% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
BDSX | WRBY | BDSX / WRBY | |
Capitalization | 58.7M | 2.85B | 2% |
EBITDA | -27.47M | 24.9M | -110% |
Gain YTD | -73.824 | -3.635 | 2,031% |
P/E Ratio | N/A | N/A | - |
Revenue | 74.5M | 795M | 9% |
Total Cash | 17.6M | 265M | 7% |
Total Debt | 62.3M | 224M | 28% |
BDSX | WRBY | |
---|---|---|
RSI ODDS (%) | 4 days ago85% | 4 days ago70% |
Stochastic ODDS (%) | 4 days ago90% | 4 days ago79% |
Momentum ODDS (%) | 4 days ago90% | 4 days ago73% |
MACD ODDS (%) | N/A | 4 days ago87% |
TrendWeek ODDS (%) | 4 days ago81% | 4 days ago76% |
TrendMonth ODDS (%) | 4 days ago82% | 4 days ago84% |
Advances ODDS (%) | 20 days ago82% | 21 days ago85% |
Declines ODDS (%) | 12 days ago90% | 4 days ago79% |
BollingerBands ODDS (%) | 4 days ago90% | 4 days ago68% |
Aroon ODDS (%) | 4 days ago80% | 4 days ago77% |
A.I.dvisor tells us that BDSX and ELMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDSX and ELMD's prices will move in lockstep.
Ticker / NAME | Correlation To BDSX | 1D Price Change % | ||
---|---|---|---|---|
BDSX | 100% | -10.40% | ||
ELMD - BDSX | 31% Poorly correlated | -0.05% | ||
PLSE - BDSX | 26% Poorly correlated | -0.07% | ||
WRBY - BDSX | 24% Poorly correlated | -0.64% | ||
MYGN - BDSX | 24% Poorly correlated | +3.61% | ||
SMTI - BDSX | 24% Poorly correlated | +1.81% | ||
More |
A.I.dvisor indicates that over the last year, WRBY has been loosely correlated with STE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if WRBY jumps, then STE could also see price increases.
Ticker / NAME | Correlation To WRBY | 1D Price Change % | ||
---|---|---|---|---|
WRBY | 100% | -0.64% | ||
STE - WRBY | 45% Loosely correlated | +2.80% | ||
TWST - WRBY | 39% Loosely correlated | +2.56% | ||
ARAY - WRBY | 36% Loosely correlated | +5.30% | ||
GKOS - WRBY | 35% Loosely correlated | -3.81% | ||
GMED - WRBY | 34% Loosely correlated | +8.47% | ||
More |